Pédiatrie Tumeurs cérébrales
CDRB436G2201
Phase II Open-label Global Study to Evaluate the Effect of Dabrafenib in Combination With Trametinib in Children and Adolescent Patients With BRAF V600 Mutation Positive Low Grade Glioma (LGG) or Relapsed or Refractory High Grade Glioma (HGG)
Paris
ISABELLE AERTS
Pédiatrie Hématologie
EURONET-PHL-C2
European Network-Paediatric Hodgkin Lymphoma Study Group (EuroNet-PHL) Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents
Paris
HELENE PACQUEMENT
VADS
CA209-9T9 ProNiHN
A FRENCH, PROSPECTIVE, NON-INTERVENTIONAL RESEARCH (NIR) OF NIVOLUMAB IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) PROGRESSING ON OR AFTER PLATINUM-BASED THERAPY
Paris
CHRISTOPHE LE TOURNEAU
Pédiatrie Sarcomes
CombinaiR3
First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years
Paris
VALERIE LAURENCE
Pédiatrie Sarcomes
COTESARC (pédiatrie)
multicentre, open-label, Phase I-II study evaluating the combination of a MEK inhibitor and a PDL1 inhibitor in pediatric and adult patients with locally advanced and/or metastatic soft tissue sarcoma
Paris
ISABELLE AERTS
Pédiatrie Sarcomes
E7080-G000-230 OLIE
A Multicenter, Open-label, Randomized Phase 2 Study to Compare the Efficacy and Safety of;Lenvatinib in Combination with Ifosfamide and Etoposide versus Ifosfamide and Etoposide in;Children, Adolescents and Young Adults with Relapsed or Refractory Osteosarcoma
Paris
ISABELLE AERTS
Sarcomes
J1S-MC-JV01
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor
Paris
SOPHIE PIPERNO-NEUMANN
Sarcomes
J1S-MC-JV02
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
Paris
SOPHIE PIPERNO-NEUMANN